Tag Archives: Novartis

Novartis, Medicines for Malaria Venture launch a novel compound against multidrug-resistant malaria

Ahead of the World Malaria Day, Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite. The trial will test the efficacy of KAF156 in combination with a new, improved formulation of the existing antimalarial lumefantrine.

Top